Holen Sie sich die Stockscreener-App
9.03
2.59%
-0.24
Handel nachbörslich:
9.00
-0.03
-0.33%
Schlusskurs vom Vortag:
$9.27
Offen:
$9.4
24-Stunden-Volumen:
1.15M
Relative Volume:
0.49
Marktkapitalisierung:
$1.49B
Einnahmen:
$177.28M
Nettoeinkommen (Verlust:
$-195.24M
KGV:
-6.7388
EPS:
-1.34
Netto-Cashflow:
$-114.54M
1W Leistung:
-8.23%
1M Leistung:
+7.76%
6M Leistung:
+55.15%
1J Leistung:
+153.65%
1-Tages-Spanne:
$9.025
$9.5029
1-Wochen-Bereich:
$8.375
$10.20
52-Wochen-Spanne:
$2.99
$10.28
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Vergleichen Sie ADPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
9.03 | 1.49B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Brokerages Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) Price Target at $9.50 - Defense World
Trading Day Review: Adaptive Biotechnologies Corp (ADPT) Loses Momentum, Closing at 8.81 - DWinneX
MetLife Investment Management LLC Acquires 3,650 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies (ADPT) Price Target Raised by Piper Sandler | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Reaches Analyst Target Price - Nasdaq
ADPT Price Target Increased to $13 by Piper Sandler | ADPT Stock News - GuruFocus
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading Volume Following Analyst Upgrade - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $9.00 at Morgan Stanley - Defense World
Adaptive Biotechnologies (ADPT) Price Target Raised by Morgan St - GuruFocus
5 Analysts Assess Adaptive Biotechnologies: What You Need To Know - Benzinga
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Stock Forecast: Downside Of -42.28% By 2025 - Stocksregister
Adaptive Biotechnologies (ADPT) Price Target Raised by Morgan Stanley | ADPT Stock News - GuruFocus
Adaptive Biotechnologies (ADPT) Price Target Increased by Morgan Stanley | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Stock Position Lifted by Wells Fargo & Company MN - Defense World
Adaptive Biotechnologies Soars 120% In 9 MonthsCan The Momentum Continue? - RTTNews
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57 - Yahoo Finance
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2025 Earnings Call Transcript - Insider Monkey
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 12-Month High Following Earnings Beat - Defense World
Decoding Adaptive Biotechnologies Corp (ADPT): A Strategic SWOT Insight - GuruFocus
Adaptive Biotechnologies stock soars on Q1 earnings beat By Investing.com - Investing.com Canada
Adaptive Biotechnologies stock soars on Q1 earnings beat - Investing.com
Adaptive Biotechnologies Corp (ADPT) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga
Adaptive Biotechnologies Lifts Forecasts And Sees Share Price Jump - Finimize
Adaptive Biotechnologies (ADPT): Goldman Sachs Raises Price Target | ADPT Stock News - GuruFocus
Adaptive Biotechnologies rises after quarterly sales beat - TradingView
Adaptive Biotechnologies (ADPT) Soars 34% on Strong Q1 Earnings - RagingBull
Adaptive Biotechnologies: Q1 Earnings Snapshot - marketscreener.com
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highl - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings: EPS of -$ - GuruFocus
Adaptive Biotechnologies Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Adaptive Biotechnologies (ADPT) Reports Strong Q1 2025 Earnings with Raised Guidance - GuruFocus
Adaptive Biotechnologies (ADPT) Surpasses Q1 Revenue Expectations | ADPT Stock News - GuruFocus
Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast By Investing.com - Investing.com South Africa
Adaptive Biotechnologies Q1 2025 slides: MRD revenue jumps 34%, expenses decline - Investing.com Canada
Adaptive Biotechnologies Q1 2025 slides: MRD revenue jumps 34%, expenses decline By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast - Investing.com
Adaptive Biotechnologies earnings beat by $0.09, revenue topped estimates - Investing.com
Adaptive Biotechnologies Corp SEC 10-Q Report - TradingView
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - TradingView
Earnings Flash (ADPT) Adaptive Biotechnologies Reports Q1 Revenue $52.4M, vs. FactSet Est of $42.7M - marketscreener.com
Taking the lead: Adaptive Biotechnologies Corp (ADPT) - Sete News
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
XTX Topco Ltd Purchases New Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - The AM Reporter
What technical indicators reveal about ADPT stock - uspostnews.com
Renaissance Technologies LLC Increases Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - American Banking and Market News
Renaissance Technologies LLC Buys 60,385 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):